Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("ETOPOSIDE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4473

  • Page / 179
Export

Selection :

  • and

EFFECTS OF THE EPIPODOPHYLLOTOXIN VP-16-213 ON CELL CYCLE TRAVERSE, DNA SYNTHESIS, AND DNA STRAND SIZE IN CULTURES OF HUMAN LEUKEMIC LYMPHOBLASTS = EFFETS DE L'EPIPODOPHYLLOTOXINE VP-16-213 SUR LE DEROULEMENT DU CYCLE CELLULAIRE, LA SYNTHESE DU DNA ET LA TAILLE DES BRINS DU DNA DANS LES CULTURES DE LYMPHOBLASTES LEUCEMIQUES HUMAINSKALWINSKY DK; LOOK AT; DUCORE J et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 4; PP. 1592-1597; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

PROCEEDINGS OF THE GERMAN CANCER SOCIETY (CLINICAL ONCOLOGY SECTION) AND BRISTOL-MYERS GMBH SYMPOSIUM ON ETOPOSIDE (VP-16), CURRENT STATUS AND NEW DEVELOPMENTS, FRANKFURT, 21-22 MAY 1981HELLMANN K ED; HILGARD P ED.1982; CANCER TREAT. REV.; ISSN 0305-7372; GBR; DA. 1982; SUPPL. A; 143 P.; BIBL. DISSEM.Conference Paper

VP-16-213 (ETOPOSIDE): THE MANDRAKE ROOT FROM ISSYK-KULVOGELZANG NJ; RAGHAVAN D; KENNEDY BJ et al.1982; AM. J. MED.; ISSN 0002-9343; USA; DA. 1982; VOL. 72; NO 1; PP. 136-144; BIBL. 101 REF.Article

ETOPOSIDE (VP-16-213)ISSELL BF; CROOKE ST.1979; CANCER TREATM. REV.; GBR; DA. 1979; VOL. 6; NO 2; PP. 107-124; BIBL. 70 REF.Article

DNA DAMAGE AS A BASIS FOR 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6,0-ETHYLIDENE-BETA -D-GLUCOPYRANOSIDE) (ETOPOSIDE) CYTOTOXICITY = LESIONS DU DNA EN TANT QUE BASE DE LA CYTOTOXICITE DU 4'-DEMETHYLEPIPODOPHYLLOTOXINE-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOS IDE) (ETOPOSIDE)WOZNIAK AJ; ROSS WE.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 1; PP. 120-124; ABS. ENG; BIBL. 15 REF.; GRAPH, FIGArticle

THERAPEUTISCHE ERFAHRUNGEN MIT DEM NEUEN PODOPHYLLOTOXINDERIVAT VP 16-213 BEI MENSCHLICHEN MALIGNEN TUMOREN. = RESULTATS THERAPEUTIQUES DU TRAITEMENT DE TUMEURS MALIGNES HUMAINES PAR UN DERIVE DE LA PODOPHYLLOTOXINE, LE VP 16-213JUNGI WF; SENN HJ; BECKMANN C et al.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1975; VOL. 105; NO 42; PP. 1365-1369; ABS. ANGL.; BIBL. 15 REF.Article

INTERNATIONAL SYMPOSIUM ON THE PODOPHYLLOTOXINS IN CANCER THERAPY, SOUTHAMPTON, ENGLAND, JULY 8-9, 1981CARTER SK ED; MATHE G ED; MCELWAIN T ED et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 7; NO 2-3; 163 P.; BIBL. DISSEM.Conference Paper

CLINICAL TRIAL OF THE ORAL FORM OF A NEW PODOPHYLLATOXIN DERIVATIVE, VP-16-213 (NSC-141540), IN PATIENTS WITH ADVANCED NEOPLASTIC DISEASE.NISSEN NI; HANSEN HH; PEDERSEN H et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1027-1029; BIBL. 5 REF.Article

EPEG, A NEW ANTINEOPLASTIC EPIPODOPHYLLOTOXIN.CREAVEN PJ; ALLEN LM.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 221-226; BIBL. 8 REF.Article

Flow cytometric fluorescence pulse width analysis of etoposide-induced nuclear enlargement in HCT116 cellsKYUNGSU KANG; SAET BYOUL LEE; YOO, Ji-Hye et al.Biotechnology letters. 2010, Vol 32, Num 8, pp 1045-1052, issn 0141-5492, 8 p.Article

PILOT STUDIES OF VARIOUS COMBINATIONS OF DIBROMODULCITOL, VP-16, AND AMSAEAGAN RT.1982; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1982; VOL. 39; NO 5; PP. 295-297; BIBL. 5 REF.Article

PHASE II EVALUATION OF VP-16-213 (NSC-141540) AND CYTEMBENA (NSC-104801) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 633-635; BIBL. 1 REF.Article

TERATOGENIC AND CYTOGENIC EFFECTS OF SOME PLANT-DERIVED ANTITUMOR AGENTS (VINCRISTINE, COLCHICINE, MAYTANSINE, VP-16-213 AND VM-26) IN MICESIEBER SM; WHANG PENG J; BOTKIN C et al.1978; TERATOLOGY; USA; DA. 1978; VOL. 18; NO 1; PP. 31-48; BIBL. 1 P.Article

ETOPOSIDE: AN EFFECTIVE SINGLE DRUG FOR TREATING BRONCHOGENIC CARCINOMAANDERSON G; PEEL ET; CHEONG CMB et al.1982; CLIN. ONCOL.; ISSN 0305-7399; GBR; DA. 1982; VOL. 8; NO 3; PP. 215-218; BIBL. 3 REF.Article

PODOPHYLLOTOXIN DERIVATIVES VP-16 AND VM-26D'INCALCI M; GARATTINI S.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 87-94; BIBL. 57 REF.Article

ETOPOSIDE: A NEW ANTI-CANCER AGENTARNOLD AM; WHITEHOUSE JMA.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8252; PP. 912-915; BIBL. 51 REF.Article

PHASE II STUDY OF VP-16-213 IN CHILDHOOD MALIGNANT DISEASE: A CHILDREN'S CANCER STUDY GROUP REPORTCHARD RL JR; KRIVIT W; BLEYER WA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1755-1759; BIBL. 12 REF.Article

COMBINATION CHEMOTHERAPY WITH 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4-6,0 ETHYLIDENE-BETA -D-GLUCOPYRANOSIDE) VP-16-213 (NSC 141540) IN L1210 LEUKEMIADOMBERNOWSKY P; NISSEN NI.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 3; PP. 181-188; BIBL. 1 P.Article

VP 16-213 IN ACUTE MYELOGENOUS LEUKAEMIASMITH IE; GERKEN ME; CLINK HM et al.1976; POSTGRAD. MED. J.; G.B.; DA. 1976; VOL. 52; NO 604; PP. 66-70; BIBL. 5 REF.Article

CYTOFLUOROMETRIC STUDIES ON THE ACTION OF PODOPHYLLOTOXIN AND EPIPODOPHYLLOTOXINS (VM-26, VP-16-213) ON THE CELL CYCLE TRAVERSE OF HUMAN LYMPHOBLASTS. = ETUDES CYTOFLUORIMETRIQUES SUR L'ACTION DE LA PODOPHYLLOTOXINE ET DES EPIPODOPHYLLOTOXINES (VM-26, VP-16-213) SUR LE DEROULEMENT DU CYCLE CELLULAIRE DES LYMPHOBLASTES HUMAINSKRISHAN A; PAIKA K; FREI E III et al.1975; J. CELL BIOL.; U.S.A.; DA. 1975; VOL. 66; NO 3; PP. 521-530; BIBL. 25 REF.Article

RESPONSE OF L1210 TO COMBINATIONS OF CYTOSINE ARABINOSIDE AND VM-26 OR VP16-213. = REPONSE DE L1210 A DES TRAITEMENTS COMBINES CYTOSINE ARABINOSIDE+VM-26 OU +VP16-213RIVERA G; AVERY T; ROBERTS D et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 9; PP. 639-647; BIBL. 1 P. 1/2Article

IN VITRO CYTOTOXICITY OF VP 16 ON PRIMARY TUMOR AND METASTASIS OF LEWIS LUNG CARCINOMAD'INCALCI M; ERBA E; VAGHI M et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 4; PP. 377-380; BIBL. 11 REF.Article

ERFOLGREICHE BEHANDLUNG DES CHRONISCHEN MYELOMONOZYTAEREN LEUKAEMIE MIT VP 16-213 = EFFICACITE DU TRAITEMENT DE LA LEUCEMIE MYELOMONOCYTAIRE CHRONIQUE PAR LE VP 16213LABEDZKI L; ILLIGER HJ.1979; BLUT; DEU; DA. 1979; VOL. 38; NO 5; PP. 421-424; ABS. ENG; BIBL. 10 REF.Article

NEUE SUBSTANZEN IN DER ONKOLOGISCHEN THERAPIE. = NOUVEAUX PRODUITS EN CANCEROLOGIECAVALLI F.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 32; PP. 1222-1227; ABS. ENG; BIBL. 62 REF.Article

COMPARISON OF THE HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, TWO ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES.ALLEN LM; CREAVEN PJ.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 10; PP. 697-707; BIBL. 2 P. 1/2Article

  • Page / 179